Cargando…

Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy

Detalles Bibliográficos
Autores principales:	Latifi-Navid, Saeid, Safaralizadeh, Reza, Wei, Lixuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267465/ https://www.ncbi.nlm.nih.gov/pubmed/37324007 http://dx.doi.org/10.3389/fonc.2023.1210866

Ejemplares similares

Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients
por: Amoozgar, Zohreh, et al.
Publicado: (2023)

Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2020)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
por: Amintas, Samuel, et al.
Publicado: (2021)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
por: Cai, Jun, et al.
Publicado: (2022)

Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
por: Wu, Xiao-Bo, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML
por: Ruan, Min, et al.
Publicado: (2021)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
por: Onidani, Kaoru, et al.
Publicado: (2019)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Sebastião, Mariana M., et al.
Publicado: (2020)

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
por: Sánchez-Herrero, Estela, et al.
Publicado: (2022)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients
por: Barbosa, Ana, et al.
Publicado: (2021)

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients
por: Wang, Ye, et al.
Publicado: (2021)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
por: Buzdin, Anton, et al.
Publicado: (2021)

Next-Generation in vivo Modeling of Human Cancers
por: Gargiulo, Gaetano
Publicado: (2018)

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
por: Yang, Emily Y., et al.
Publicado: (2020)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013)

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
por: Cao, Hua, et al.
Publicado: (2020)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Editorial: Association Between Human Cancers and Small DNA Tumor Viruses
por: Tognon, Mauro
Publicado: (2020)

The Role of Circulating Biomarkers in Lung Cancer
por: Herath, Sayuri, et al.
Publicado: (2022)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
por: van Rees, Jan M., et al.
Publicado: (2023)

Cancer Immunotherapy and Next-Generation Clinical Immune Assessment
por: Ma, Chao, et al.
Publicado: (2014)

Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)

Editorial: Molecular Biomarkers for Gastric Cancer
por: Hong, Xinqiang, et al.
Publicado: (2022)

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
por: Miljkovic, Milos D., et al.
Publicado: (2021)

Editorial: Minimally-invasive treatment for genitourinary cancers: what comes next?
por: Chierigo, Francesco, et al.
Publicado: (2023)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_59v96kpjhdn0t35qb5sbjmn6gj